huntsman

Huntsman and Hexion Specialty Chemicals said that their proposed merger will not close on schedule because the banks committed to financing the deal are unwilling to lend the necessary money.

The Huntsman chemicals company says two banks providing funding for its disputed takeover by Hexion Specialty Chemicals have backed out of the deal.

Hexion Specialty Chemicals is moving to complete its $6.51 billion buyout of Huntsman with help from Apollo Management.

Hexion Specialty Chemicals received a $540 million pledge to help it close its fiercely contested takeover of Huntsman Corp.

Chemical maker Huntsman Corporation says an outside appraisal firm believes a proposed $6.5 billion buyout by Hexion Specialty Chemicals would result in a solvent combined entity.

Hexion Specialty Chemicals Inc. said Wednesday it no longer thinks that will be able to acquire fellow chemicals maker Huntsman Corp. because of the deterioration of Huntsman's finances.

Huntsman shares fell nearly 38 percent.

StreetInsider.com Trading Radar: Endo Pharmaceuticals Holdings (Nasdaq: ENDP) is expected to report results before the open Friday with analysts looking for EPS of $0.44 and revenues of $285.7 million.

Huntsman (NYSE: HUN) is expected to report results before the open Friday with analysts looking for EPS of $0.25 and revenues of $2.28 billion.

PG&E (NYSE: PCG) is expected to report results before the open Friday with analysts looking for EPS of $0.55 and revenues of $3.15 billion.